Cargando…

Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma

BACKGROUND: Cholangiocarcinoma (CCA) is a highly malignant, heterogeneous bile duct malignancy with poor treatment options. A novel type of cell death termed cuproptosis was recently demonstrated to closely correlate with tumor progression. To gain more insight into the role of cuproptosis in CCA, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jialu, Yu, Xiaopeng, Tong, Huanjun, Tang, Chengwei, Tang, Zhaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773249/ https://www.ncbi.nlm.nih.gov/pubmed/36568224 http://dx.doi.org/10.3389/fonc.2022.1054063

Ejemplares similares

Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
por: Ye, Zhang, et al.
Publicado: (2022)

Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer
por: Liu, Yanqing, et al.
Publicado: (2022)

Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma
por: Zhao, Fangrui, et al.
Publicado: (2022)

Commentary: Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer
por: Du, Yi-Heng
Publicado: (2023)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
por: Xu, Miaorong, et al.
Publicado: (2022)

CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export
por: Yu, Xiaopeng, et al.
Publicado: (2023)

A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2022)

Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma
por: Sun, Qi, et al.
Publicado: (2022)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia
por: Li, Pian, et al.
Publicado: (2022)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma
por: Liu, Ya Jun, et al.
Publicado: (2021)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma
por: Chen, Yuqiao, et al.
Publicado: (2022)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation
por: Zhou, Liuqing, et al.
Publicado: (2022)

Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma
por: Zhang, Bingxin, et al.
Publicado: (2023)

A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma
por: Yang, Weiguang, et al.
Publicado: (2022)

Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas
por: Tang, Shouyi, et al.
Publicado: (2022)

A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
por: Luo, Bixian, et al.
Publicado: (2022)

Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
por: Yalimaimaiti, Saiyidan, et al.
Publicado: (2023)

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)

Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Cuproptosis in ccRCC: key player in therapeutic and prognostic targets
por: Lv, Yang, et al.
Publicado: (2023)

Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
por: Chen, Yuqiao, et al.
Publicado: (2023)

Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma
por: Hu, Hai, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma
por: Jin, Ze, et al.
Publicado: (2022)

Identification of a cuproptosis and copper metabolism gene–related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma
por: Yuan, Wei, et al.
Publicado: (2023)

The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression
por: Zhao, Qianwen, et al.
Publicado: (2023)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)

A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
por: Li, Yaoting, et al.
Publicado: (2023)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

Identification of Cuproptosis-Related Subtypes, Establishment of a Prognostic Signature and Characterization of the Tumor Microenvironment in Gastric Cancer
por: Li, Jiazheng, et al.
Publicado: (2023)

Molecular subtypes and tumor microenvironment infiltration signatures based on cuproptosis-related genes in colon cancer
por: Luo, Hongwei, et al.
Publicado: (2023)

Characterization of a cuproptosis-related signature to evaluate immune features and predict prognosis in colorectal cancer
por: Li, Lei, et al.
Publicado: (2023)

Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set
por: Liu, Hengrui, et al.
Publicado: (2022)

Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
por: Zhou, Zheng, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
por: Xu, Qi-Tong, et al.
Publicado: (2023)

Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma
por: Luo, Huan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_br9o46j31jlkpq1h5d5a4r0495